Patient Site Healthcare Professional Site
VIVITROL (naltrexone for extended-release injectable suspension) VIVITROL: A Treatment Option For The Daily Struggle Against Alcohol Dependence. One dose all month long.
Healthcare Professional Site
Prescribing Information
Send to a Friend
Homepage About Vivitrol Request Information SEARCH
About VIVITROL
My Path to Recovery
Overview


Mechanism of action


Efficacy


Dosage/Administration


Adherence


Safety Considerations


VIVITROL Preparation and Administration
What is VIP3?


How do I start a patient on therapy?

What is VIP3?

VIP3, VIVITROL Information for Patients, Physicians, and Providers, is a confidential service, designed to comply with federal privacy regulations, that offers the following:

  • Enrollment of patients and physicians in the VIP3 program
  • Identification and coordination of healthcare providers for injections
  • Coordination of product delivery
  • Adherence services
  • Reimbursement support services
  • Patient Assistance Program
To start a patient on therapy, you should enroll the patient in the VIP3 program.

Learn how to enroll patients

For additional information about the VIP3 program, please call 1-800-VIVITROL (1-800-848-4876). 		VIP3 VIVITROL information for patients, physycians, providers

Important Safety Information
Naltrexone has the capacity to cause hepatocellular injury when given in excessive doses. Naltrexone is contraindicated in acute hepatitis or liver failure, and its use in patients with active liver disease must be carefully considered in light of its hepatotoxic effects. The margin of separation between the apparently safe dose of naltrexone and the dose causing hepatic injury appears to be only five-fold or less. VIVITROL does not appear to be a hepatotoxin at the recommended doses. Patients should be warned of the risk of hepatic injury and advised to seek medical attention if they experience symptoms of acute hepatitis. Use of VIVITROL should be discontinued in the event of symptoms and/or signs of acute hepatitis.
VIVITROL is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL.

Patients should not be actively drinking at the time of initial VIVITROL administration.

Treatment with VIVITROL should be part of a comprehensive management program that includes psychosocial support.